280 related articles for article (PubMed ID: 25553475)
1. Epigenetic programming contributes to development of drug resistance in hematological malignancies.
Wang QY; Zhong H
Front Biosci (Landmark Ed); 2015 Jan; 20(4):728-42. PubMed ID: 25553475
[TBL] [Abstract][Full Text] [Related]
2. Impact of Histone Modifications and Their Therapeutic Targeting in Hematological Malignancies.
Markouli M; Strepkos D; Piperi C
Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362442
[TBL] [Abstract][Full Text] [Related]
3. RNA methylation in hematological malignancies and its interactions with other epigenetic modifications.
Yao L; Yin H; Hong M; Wang Y; Yu T; Teng Y; Li T; Wu Q
Leukemia; 2021 May; 35(5):1243-1257. PubMed ID: 33767371
[TBL] [Abstract][Full Text] [Related]
4. Epimutational profile of hematologic malignancies as attractive target for new epigenetic therapies.
Fratta E; Montico B; Rizzo A; Colizzi F; Sigalotti L; Dolcetti R
Oncotarget; 2016 Aug; 7(35):57327-57350. PubMed ID: 27329599
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic therapy in hematological cancers.
Dimopoulos K; Grønbaek K
APMIS; 2019 May; 127(5):316-328. PubMed ID: 30859683
[TBL] [Abstract][Full Text] [Related]
6. Epigenetically-targeted therapies for the treatment of hematological malignancies.
Georgiou E; Kouidou S
Curr Med Chem; 2011; 18(12):1757-64. PubMed ID: 21466475
[TBL] [Abstract][Full Text] [Related]
7. [Epigenetic therapy for hematologic malignancies].
Kobayashi Y
Rinsho Ketsueki; 2015 Oct; 56(10):2015-23. PubMed ID: 26458440
[TBL] [Abstract][Full Text] [Related]
8. [A primer for epigenetics of hematological malignancies].
Nakajima H
Rinsho Ketsueki; 2016; 57(10):1835-1844. PubMed ID: 27725578
[TBL] [Abstract][Full Text] [Related]
9. Epigenetics in cancer: targeting chromatin modifications.
Ellis L; Atadja PW; Johnstone RW
Mol Cancer Ther; 2009 Jun; 8(6):1409-20. PubMed ID: 19509247
[TBL] [Abstract][Full Text] [Related]
10. Can the state of cancer chemotherapy resistance be reverted by epigenetic therapy?
Perez-Plasencia C; Duenas-Gonzalez A
Mol Cancer; 2006 Jul; 5():27. PubMed ID: 16831224
[TBL] [Abstract][Full Text] [Related]
11. EHA scientific workshop report: the role of epigenetics in hematological malignancies.
Jost E; Galm O
Epigenetics; 2007; 2(2):71-9. PubMed ID: 17965605
[TBL] [Abstract][Full Text] [Related]
12. Epigenetics in Hematological Malignancies.
Cruz-Rodriguez N; Combita AL; Zabaleta J
Methods Mol Biol; 2018; 1856():87-101. PubMed ID: 30178247
[TBL] [Abstract][Full Text] [Related]
13. Drug resistance-related microRNAs in hematological malignancies: translating basic evidence into therapeutic strategies.
Xie L; Jing R; Qi J; Lin Z; Ju S
Blood Rev; 2015 Jan; 29(1):33-44. PubMed ID: 25263425
[TBL] [Abstract][Full Text] [Related]
14. The DNA methylation landscape of hematological malignancies: an update.
Blecua P; Martinez-Verbo L; Esteller M
Mol Oncol; 2020 Aug; 14(8):1616-1639. PubMed ID: 32526054
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic therapy: histone acetylation, DNA methylation and anti-cancer drug discovery.
Ganesan A; Nolan L; Crabb SJ; Packham G
Curr Cancer Drug Targets; 2009 Dec; 9(8):963-81. PubMed ID: 20025605
[TBL] [Abstract][Full Text] [Related]
16. Epigenetics in Personalized Management of Lung Cancer.
Ahmad A
Adv Exp Med Biol; 2016; 890():111-22. PubMed ID: 26703801
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic mechanisms in tumorigenesis, tumor cell heterogeneity and drug resistance.
Wilting RH; Dannenberg JH
Drug Resist Updat; 2012; 15(1-2):21-38. PubMed ID: 22356866
[TBL] [Abstract][Full Text] [Related]
18. Asthma epigenetics.
Salam MT
Adv Exp Med Biol; 2014; 795():183-99. PubMed ID: 24162909
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic alterations and their clinical implications in esophageal squamous cell carcinoma.
Toh Y; Egashira A; Yamamoto M
Gen Thorac Cardiovasc Surg; 2013 May; 61(5):262-9. PubMed ID: 23529258
[TBL] [Abstract][Full Text] [Related]
20. Interplay between microRNAs and the epigenetic machinery: an intricate network.
Iorio MV; Piovan C; Croce CM
Biochim Biophys Acta; 2010; 1799(10-12):694-701. PubMed ID: 20493980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
